| Detected | Trial | Change |
|---|---|---|
| 2026-06-02 | NCT05998408 JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT05998408 JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure |
Enrollment reduced: 145 -> 13 participants |
| 2026-05-29 | NCT03312400 Low-Dose Danazol for the Treatment of Telomere Related Diseases |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT03312400 Low-Dose Danazol for the Treatment of Telomere Related Diseases |
Enrollment reduced: 40 -> 18 participants |
| 2026-05-29 | NCT05904093 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in… |
date change Primary completion pushed: 2026-05-14 -> 2027-05-14 |
| 2026-05-29 | NCT05904093 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in… |
date change Completion pushed: 2026-05-14 -> 2027-05-14 |
| 2026-05-16 | NCT03312400 Low-Dose Danazol for the Treatment of Telomere Related Diseases |
date change Primary completion pushed: 2026-04-29 -> 2027-04-29 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07613099 Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation… | Phase 3 | Not Yet Recruiting |
| 2026-05-20 | NCT07599176 Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors | Phase 1/2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05170399 | Vaccine Responses in Patients With B Cell Malignancies | Lymphoma | Recruiting |
| Phase 3 | |||
| NCT07613099 | Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation… | Allogeneic Stem Cell Transplantation | Not Yet Recruiting |
| Phase 2 | |||
| NCT03986034 | Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT04304820 | Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive… | Severe Aplastic Anemia | Recruiting |
| NCT06923072 | Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological… | Kohlmeier-Degos Disease | Recruiting |
| NCT01174108 | Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other… | Severe Aplastic Anemia | Recruiting |
| NCT03520647 | Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH… | Severe Aplastic Anemia (SAA) | Recruiting |
| NCT03372733 | Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults | Cardiovascular Disease | Recruiting |
| NCT02979873 | Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia… | Severe Aplastic Anemia | Active, Not Recruiting |
| NCT02514083 | A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT01500733 | PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | Leukemia | Active, Not Recruiting |
| NCT03312400 | Low-Dose Danazol for the Treatment of Telomere Related Diseases | Telomere Disease | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04008368 | Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease… | Myeloid Chimerism | Recruiting |
| NCT03173937 | Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and… | Severe Aplastic Anemia | Recruiting |
| NCT06032923 | Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With… | Systemic Lupus Erythematosus (Sle) | Recruiting |
| NCT01799538 | Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis | Lymphangioleiomyomatosis | Recruiting |
| NCT07599176 | Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors | Sickle Cell Disease | Recruiting |
| NCT05357482 | Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell… | Sickle Cell Anemia | Active, Not Recruiting |
| NCT01623167 | Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia | Severe Aplastic Anemia | Active, Not Recruiting |
| NCT00977691 | Haploidentical PBMC Transplant for Severe Congenital Anemias | Sickle Cell Anemia | Active, Not Recruiting |
| NCT03077542 | Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell… | Sickle Cell Disease | Active, Not Recruiting |
| NCT06145282 | Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease… | Sickle Cell Disease | Active, Not Recruiting |
| NCT04610866 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat… | Sickle Cell Disease | Active, Not Recruiting |
| NCT05998408 | JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure | Severe Aplastic Anemia | Active, Not Recruiting |
| Phase 1 | |||
| NCT05904093 | Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in… | Sickle Cell Disease | Recruiting |